PVAI enables leading life sciences companies to transform pharmacovigilance and patient safety through AI.

PVAI was incubated inside of Genpact to build out a modular, validated suite of industry-leading Artificial Intelligence SaaS modules developed specifically to solve the myriad challenges in Pharmacovigilance (PV). PVAI products and solutions enable life sciences companies to bring the power of cutting edge AI seamlessly into safety operations across the globe.

As of February 1, 2023 PVAI is now an independent company continuing its mission to become the industry standard for intelligence and automation in Pharmacovigilance.

Our Products

  • Intake

    Streamlined and highly scalable adverse event document triage with fully compliant audit history enabling initial processing/book-in. Intake allows organizations to implement and grow their AIML capabilities step-by-step.

  • XCE

    The core of PVAI’s SaaS solution is our Extraction and Classification Engine (XCE) that combines the power of AI, NLP and Machine Learning with sophisticated business logic to achieve faster, more efficient, and more accurate case processing.

  • Case Management

    A robust and modern adverse event case processing application that integrates the capabilities of XCE into an intuitive and effective user experience for rapid case data verification.